Book Excerpt from Women After All

In the introduction to his latest book, author Melvin Konner explains why he considers maleness a departure from normal physiology.

Written byMelvin Konner
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

W.W. NORTON & COMPANY, MARCH 2015There is a birth defect that is surprisingly common, due to a change in a key pair of chromosomes. In the normal condition the two look the same, but in this disorder one is shrunken beyond recognition. The result is shortened life span, higher mortality at all ages, an inability to reproduce, premature hair loss, and brain defects vari­ously resulting in attention deficit, hyperactivity, conduct disorder, hypersexuality, and an enormous excess of both outward and self-directed aggression. The main physiological mechanism is androgen poisoning, although there may be others. I call it the X-chromosome deficiency syndrome, and a stunning 49 percent of the human spe­cies is affected.

It is also called maleness.

My choice to call being male a syndrome and to consider it less normal than the usual alternative is not (as I will show you) an arbi­trary moral judgment. It is based on evolution, physiology, devel­opment, and susceptibility to disease. Once in our distant past, all of our ancestors could reproduce from their own bodies; in other words, we were all basically female. When biologists ask why sex evolved, they are not asking rhetorically—the fact that sex feels good was a valuable addition. What they are really asking is: Why did those self-sufficient females invent males? It had to be a very big rea­son, since they were bringing in a whole new cast of characters that took up space and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies